ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228386.2	Ponatinib	Bladder urothelial carcinoma	0.047659446	Resistant
ENSG00000228386.2	Ponatinib	Colon adenocarcinoma	0.027392403	Sensitive